ClinicalTrials.Veeva

Menu

Methocarbamol in Ventral and Inguinal HR

P

Prisma Health-Upstate

Status and phase

Enrolling
Phase 4

Conditions

Ventral Hernia
Inguinal Hernia

Treatments

Drug: Standard Opioid
Drug: Standard opioid plus methocarbamol
Drug: Methocarbamol

Study type

Interventional

Funder types

Other

Identifiers

NCT05388929
1913843

Details and patient eligibility

About

The purpose of this study is to gather information on methocarbamol as a pain management treatment for ventral or inguinal hernia repair.

Methocarbamol has been part of the pain management treatment for both inpatient and outpatient procedures at Prisma Health. This study will compare the outcomes of patients who receive methocarbamol, those who receive the standard opioid pain management treatment, and those who receive methocarbamol plus the standard opioid pain management treatment.

Participants will be randomized into one of the study groups listed below.

Primary ventral hernia repair or inguinal hernia repair:

Group 1: standard opioid after surgery Group 2: methocarbamol after surgery

Open or robotic ventral hernia repair outpatient:

Group 1: standard opioid after surgery Group 2: standard opioid plus methocarbamol after surgery

Open or robotic ventral hernia repair inpatient:

Group 1: standard opioid at discharge Group 2: standard opioid plus methocarbamol at discharge

A total of 200 participants will be included in the study.

Participation will last for about 30 days after surgery.

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • >18 y/o
  • Patients undergoing open primary ventral hernia repair (group 1)
  • Patients undergoing inguinal hernia repair (open, laparoscopic, or robotic; group 2)
  • Patients undergoing open incisional hernia repair (group 3)
  • Robotic repair ventral or incisional hernias (group 4)
  • Given consent for randomization

Exclusion criteria

  • <18 y/o
  • Pregnancy
  • Chronic opioid users

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

200 participants in 3 patient groups

primary ventral hernia repair or inguinal hernia repair
Experimental group
Description:
Primary ventral hernias, including umbilical, epigastric, and Spigelian hernias. Primary or recurrent inguinal hernias.
Treatment:
Drug: Methocarbamol
Drug: Standard Opioid
open or robotic ventral hernia repair outpatient
Experimental group
Description:
Open repair of ventral incisional hernias. Robotic repair of ventral primary or incisional hernias.
Treatment:
Drug: Standard opioid plus methocarbamol
Drug: Standard Opioid
open or robotic hernia repair inpatient
Experimental group
Description:
Open repair of ventral incisional hernias. Robotic repair of ventral primary or incisional hernias.
Treatment:
Drug: Standard opioid plus methocarbamol
Drug: Standard Opioid

Trial contacts and locations

1

Loading...

Central trial contact

Jeremy A Warren, MD; Aimee N Hanvey, MS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems